Stem Cells News and Research

RSS

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

New cell-based technologies could help improve understanding of muscle-wasting disease

Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.

6 Jun 2018

Study reveals how pesticides cause Parkinson's Disease

A recent study has shown that pesticides prevent mitochondria from functioning correctly, causing cell death and Parkinson’s Disease.

6 Jun 2018

Scientists uncover 'Achilles heel' in deadly form of brain cancer

Scientists at Virginia Commonwealth University believe they have uncovered an "Achilles heel" of glioblastoma multiforme, the most common and deadly form of brain cancer.

5 Jun 2018

Researchers develop novel microscopy to observe cellular focal adhesion dynamics

Focal adhesions are large specialized proteins that are located in the area where a cell membrane meets the extracellular matrix, a collection of molecules surrounding the cells that provide support and regulate micromechanical signals to the cells.

4 Jun 2018

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.

1 Jun 2018

Study reveals how the brain coordinates complex articulatory movements during natural speech

When we speak, we engage nearly 100 muscles, continuously moving our lips, jaw, tongue, and throat to shape our breath into the fluent sequences of sounds that form our words and sentences. A new study by UC San Francisco scientists reveals how these complex articulatory movements are coordinated in the brain.

1 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

UK scientists 3D-print the first human corneas

For the first time in history, scientists from have 3D-printed human corneas, providing a potential solution to the current shortage of corneas for transplant.

1 Jun 2018

Researchers discover three genes that may have contributed to evolution of large human brain

Three genes involved in nerve cell generation in the brain emerged roughly 3.5 million years ago and may have contributed to the rapid evolution of the large human brain, Howard Hughes Medical Institute (HHMI) Investigator David Haussler and colleagues report on May 31, 2018, in the journal Cell.

1 Jun 2018

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world.

31 May 2018

UTSA scientists explore stuttering and develop new technology to optimize brain function

A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.

31 May 2018

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

30 May 2018

Study shows blood stem cells compensate for immune cell deficiencies

Researchers have shown that if certain blood stem cells that produce immune cells are deficient, other blood stem cells compensate by overproducing the immune cells that are lacking.

30 May 2018

Defective energy production may explain why our brains are prone to age-related diseases

Defective energy production in old neurons might explain why our brains are so prone to age-related diseases.

30 May 2018

Genomic medicine may redefine cardiovascular care in future, shows study

A new scientific statement from the American Heart Association summarizes the state-of-the-science of genomic medicine -- the study of the health effects of the molecular interactions of a person's unique genes -- for studying cardiovascular traits and disorders and for therapeutic screening.

29 May 2018

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Gregory Pence, Ph.D., professor and Chair of Philosophy, teaches bioethics at the University of Alabama at Birmingham.

26 May 2018

Novoheart announces next generation of 'Human heart-in-a-jar' technology for advanced drug discovery

Novoheart today announced that the next generation of its ‘Human heart-in-a-jar’ technology - which makes up a key component of its comprehensive MyHeartTM Platform - will be unveiled for the first time at the Annual Meeting of the International Society for Stem Cell Research, held in Melbourne, Australia from 20-23 June, 2018.

26 May 2018

Stem Cells News and Research

Further Reading

New cell-based technologies could help improve understanding of muscle-wasting disease

Study reveals how pesticides cause Parkinson's Disease

Scientists uncover 'Achilles heel' in deadly form of brain cancer

Researchers develop novel microscopy to observe cellular focal adhesion dynamics

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Study reveals how the brain coordinates complex articulatory movements during natural speech

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

UK scientists 3D-print the first human corneas

Researchers discover three genes that may have contributed to evolution of large human brain

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

UTSA scientists explore stuttering and develop new technology to optimize brain function

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Study shows blood stem cells compensate for immune cell deficiencies

Defective energy production may explain why our brains are prone to age-related diseases

Genomic medicine may redefine cardiovascular care in future, shows study

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Novoheart announces next generation of 'Human heart-in-a-jar' technology for advanced drug discovery

Researchers work together to solve mystery of motor neuron death in ALS patients

New research will use mathematics to solve mysteries in cell biology

Researchers discover cascade of immune processes linked to poor outcomes in aggressive breast cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo